Empowered Funds, LLC

Position in DXCM — Dexcom Inc

CIK 1592828 NEWTOWN SQUARE, PA

Position in DXCM

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$1,695,669

+$588,948 QoQ

Shares Held

25,177

+42.9% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#408

of 966 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Empowered Funds, LLC holds $93,312,876 across 21 Medical Devices names. DXCM ranks #13 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVCR	NovoCure Ltd	1,154,431	$17,489,629
2	ABT	Abbott Laboratories	166,065	$15,068,733
3	MDT	Medtronic plc	162,087	$12,680,060
4	SYK	Stryker Corp	28,726	$9,044,091
5	AHCO	AdaptHealth Corp.	646,861	$6,740,291
6	BSX	Boston Scientific Corp	114,625	$4,892,191
7	QDEL	QuidelOrtho Corp	267,989	$4,695,167
8	EW	Edwards Lifesciences Corp	43,120	$3,900,633

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,695,669	25,177	+42.9%	Shares	Other	2026-08-17
2026-03-31	$1,106,721	17,623	+37.4%	Shares	Sole	2026-05-15
2025-09-30	$863,262	12,829	+9.8%	Shares	Other	2025-11-13
2025-06-30	$1,019,634	11,681	+38.3%	Shares	Sole	2025-08-11
2025-03-31	$576,776	8,446	+5.4%	Shares	Sole	2025-05-16
2024-12-31	$622,937	8,010	+37.0%	Shares	Other	2025-01-28
2024-09-30	$391,982	5,847	+6.1%	Shares	Other	2024-11-06
2024-06-30	$624,950	5,512	-0.1%	Shares	Other	2024-07-30
2024-03-31	$765,346	5,518	+30.7%	Shares	Sole	2024-05-06
2023-12-31	$524,032	4,223	+24.1%	Shares	Other	2024-02-14
2023-09-30	$317,499	3,403	+29.7%	Shares	Other	2023-11-01
2023-06-30	$337,081	2,623	-18.1%	Shares	Other	2023-07-27
2021-12-31	$1,718,776	3,201	-5.5%	Shares	Sole	2022-02-10
2020-09-30	$1,396,223	3,387	-2.7%	Shares	Sole	2020-10-26
2020-06-30	$1,411,602	3,482	-18.3%	Shares	Sole	2020-07-16
2020-03-31	$1,147,090	4,260	—	Shares	Sole	2020-04-16
No filing history on record for this holder in this stock.